Gene-edited xenotransplantation: Industries
Industries
The industries and kinds of firm that use or make it, how far they have taken it up and what it does to them
Used by- Hospitals and specialty hospital chains Experimental transplants Transplant centres such as NYU Langone, the University of Maryland and Massachusetts General Hospital performed the first operations [1, 2, 4].
- Innovator pharma and biotech companies New kind of product Biotechnology firms breed and supply the edited pigs: Revivicor, a regenerative medicine company, supplied the 2022 heart [3] and eGenesis the 2024 kidney [4].
- Drug regulators and pharmacopoeias Decides when trials and use may start The FDA allowed clinical trials with living patients only from the autumn of 2025 [5].
as of 2026-11-11
Sources
- First Gene-Edited Pig Kidney Transplant Clinical Trial Begins at NYU Langone Health NYU Langone Health, 2025
- University of Maryland School of Medicine Faculty Scientists and Clinicians Publish Findings of World's First Successful Transplant of Genetically Modified Pig Heart into Human Patient University of Maryland School of Medicine, 2022
- University of Maryland School of Medicine Faculty Scientists and Clinicians Perform Historic First Successful Transplant of Porcine Heart into Adult Human with End-Stage Heart Disease University of Maryland School of Medicine, 2022
- World's First Genetically-Edited Pig Kidney Transplant into Living Recipient Performed at Massachusetts General Hospital Mass General Brigham, 2024
- Pig Kidney Transplants in Humans: Xenotransplantation Explained by Experts National Kidney Foundation, 2026